Order Article Reprints

Scharf C, Paal M, Schroeder I, Vogeser M, Draenert R, Irlbeck M, Zoller M, Liebchen U. Therapeutic Drug Monitoring of Meropenem and Piperacillin in Critical Illness—Experience and Recommendations from One Year in Routine Clinical Practice. Antibiotics. 2020; 9(3):131. https://doi.org/10.3390/antibiotics9030131

Scharf, Christina, Michael Paal, Ines Schroeder, Michael Vogeser, Rika Draenert, Michael Irlbeck, Michael Zoller, and Uwe Liebchen. 2020. "Therapeutic Drug Monitoring of Meropenem and Piperacillin in Critical Illness—Experience and Recommendations from One Year in Routine Clinical Practice" Antibiotics 9, no. 3: 131. https://doi.org/10.3390/antibiotics9030131

Scharf, C., Paal, M., Schroeder, I., Vogeser, M., Draenert, R., Irlbeck, M., Zoller, M., & Liebchen, U. (2020). Therapeutic Drug Monitoring of Meropenem and Piperacillin in Critical Illness—Experience and Recommendations from One Year in Routine Clinical Practice. Antibiotics, 9(3), 131. https://doi.org/10.3390/antibiotics9030131